Skip to main content
Midas Edge

BIOLIFE SOLUTIONS INC

For the period ended Nov 6, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 6, 2025 · Filed Nov 6, 2025

Use the contents to explore the available documents and sections.

BLFS$38.61+3.5%Stored close · as of Oct 5, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.1 · ADJUSTED EBITDA

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP measure, for the third quarter of 2025 was $7.8 million, or 28% of revenue, compared with $5.0 million, or 23% of revenue, for the third quarter of 2024.

Adjusted EBITDA, a non-GAAP measure, for the nine months ended September 30, 2025 was $19.7 million, or 25% of revenue, compared with $11.6 million, or 19% of revenue, for the same period in 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.